Skip to main content
Discovering the causes of cancer and the means of prevention
 

Pleuropulmonary Blastoma DICER1 Syndrome Study

Doctor examining baby

The Pleuropulmonary (PPB) DICER1 Syndrome Study is an observational study of individuals with PPB and/or other DICER1-related tumors and their families. The study seeks to define the tumor types and risks associated with the DICER1 syndrome. Investigators also seek to understand why some individuals with a change in DICER1 develop cancer while others remain healthy.

To carry out this study, the Clinical Genetics Branch is partnering with leading research groups, including:

For more information, contact Douglas Stewart, M.D.

Information for Participants

All individuals with PPB or related tumors and conditions and their family members are encouraged to participate. Visit the participant recruitment website.

Phone: 1-800-518-8474 to speak with the referral nurse
Email: NCI.PPB@westat.com

Read the study summary on ClinicalTrials.gov.

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Pleuropulmonary Blastoma DICER1 Syndrome Study was originally published by the National Cancer Institute.”